Tuesday, September 15, 2020

Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Drugs Controller General of India Dr VG Somani gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country.

from NDTV News - Latest https://ift.tt/2Rxkbqa
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

JP Morgan Names Two New Co-Presidents As Bank Searches For CEO Jamie Dimon’s Successor

Apart from becoming JP Morgan’s new co-presidents, both Doug Petno and Troy Rohrbaugh have been awarded one-time restricted stock bonuses of...